ReviewTargeted oncology2018

Inotuzumab Ozogamicin: A Review in Relapsed/Refractory B-Cell Acute Lymphoblastic Leukaemia.

Zaina T Al-SalamaPubMed ↗Publisher ↗

No numbers read from the abstract.